Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Shaheen

Showing results (111-120 of 117) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 117 results.
Nature Biomedical Engineering|October 16, 2019
Sustained perfusion of revascularized bioengineered livers heterotopically transplanted into immunosuppressed pigsMohammed F Shaheen, Dong Jin Joo, Jeffrey J Ross, et al.
Nature Biomedical Engineering|November 7, 2019
Author Correction: Sustained perfusion of revascularized bioengineered livers heterotopically transplanted into immunosuppressed pigsMohammed F Shaheen, Dong Jin Joo, Jeffrey J Ross, et al.
Cancer Immunology, Immunotherapy : CII|August 31, 2022
Divergent clinical outcomes in a phase 2B trial of the TLPLDC vaccine in preventing melanoma recurrence and the impact of dendritic cell collection methodology: a randomized clinical trialAlexandra M Adams, Elizabeth L Carpenter, Guy T Clifton, et al.
Journal for Immunotherapy of Cancer|August 3, 2023
Prospective, randomized, double-blind phase 2B trial of the TLPO and TLPLDC vaccines to prevent recurrence of resected stage III/IV melanoma: a prespecified 36-month analysisElizabeth Lee Carpenter, Spencer Van Decar, Alexandra M Adams, et al.
Journal of Translational Medicine|September 22, 2020
Transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to animals: an updated reviewSina Salajegheh Tazerji, Phelipe Magalhães Duarte, Parastoo Rahimi, et al.
Gene Reports|January 24, 2022
Global data analysis and risk factors associated with morbidity and mortality of COVID-19Sina Salajegheh Tazerji, Fatemeh Shahabinejad, Mahya Tokasi, et al.
Journal for Immunotherapy of Cancer|October 2, 2021
Multicenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in patients with post-resection melanoma at high risk of recurrenceCraig L Slingluff, Karl D Lewis, Robert Andtbacka, et al.
Pageof 12

Showing results (111-120 of 117) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 117 results.
Nature Biomedical Engineering|October 16, 2019
Sustained perfusion of revascularized bioengineered livers heterotopically transplanted into immunosuppressed pigsMohammed F Shaheen, Dong Jin Joo, Jeffrey J Ross, et al.
Nature Biomedical Engineering|November 7, 2019
Author Correction: Sustained perfusion of revascularized bioengineered livers heterotopically transplanted into immunosuppressed pigsMohammed F Shaheen, Dong Jin Joo, Jeffrey J Ross, et al.
Cancer Immunology, Immunotherapy : CII|August 31, 2022
Divergent clinical outcomes in a phase 2B trial of the TLPLDC vaccine in preventing melanoma recurrence and the impact of dendritic cell collection methodology: a randomized clinical trialAlexandra M Adams, Elizabeth L Carpenter, Guy T Clifton, et al.
Journal for Immunotherapy of Cancer|August 3, 2023
Prospective, randomized, double-blind phase 2B trial of the TLPO and TLPLDC vaccines to prevent recurrence of resected stage III/IV melanoma: a prespecified 36-month analysisElizabeth Lee Carpenter, Spencer Van Decar, Alexandra M Adams, et al.
Journal of Translational Medicine|September 22, 2020
Transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to animals: an updated reviewSina Salajegheh Tazerji, Phelipe Magalhães Duarte, Parastoo Rahimi, et al.
Gene Reports|January 24, 2022
Global data analysis and risk factors associated with morbidity and mortality of COVID-19Sina Salajegheh Tazerji, Fatemeh Shahabinejad, Mahya Tokasi, et al.
Journal for Immunotherapy of Cancer|October 2, 2021
Multicenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in patients with post-resection melanoma at high risk of recurrenceCraig L Slingluff, Karl D Lewis, Robert Andtbacka, et al.
Pageof 12